Anthem Company Profile (NYSE:ANTM)

About Anthem (NYSE:ANTM)

Anthem logoAnthem, Inc. is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products. It also provides an array of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs and other administrative services. It provides an array of specialty and other insurance products and services, such as dental, vision, life and disability insurance benefits and radiology benefit management.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Managed Health Care - NEC
  • Sub-Industry: Managed Health Care
  • Symbol: NYSE:ANTM
  • CUSIP: 94973V10
  • Web:
  • Market Cap: $48.63 billion
  • Outstanding Shares: 264,986,000
Average Prices:
  • 50 Day Moving Avg: $189.96
  • 200 Day Moving Avg: $172.84
  • 52 Week Range: $114.85 - $194.94
  • Trailing P/E Ratio: 17.69
  • Foreward P/E Ratio: 14.12
  • P/E Growth: 1.42
Sales & Book Value:
  • Annual Revenue: $87.08 billion
  • Price / Sales: 0.56
  • Book Value: $98.43 per share
  • Price / Book: 1.86
  • Annual Dividend: $2.60
  • Dividend Yield: 1.4%
  • EBIDTA: $6.01 billion
  • Net Margins: 3.19%
  • Return on Equity: 13.13%
  • Return on Assets: 5.01%
  • Debt-to-Equity Ratio: 0.59%
  • Current Ratio: 1.64%
  • Quick Ratio: 1.64%
  • Average Volume: 1.49 million shs.
  • Beta: 0.73
  • Short Ratio: 4.48
Frequently Asked Questions for Anthem (NYSE:ANTM)

What is Anthem's stock symbol?

Anthem trades on the New York Stock Exchange (NYSE) under the ticker symbol "ANTM."

How often does Anthem pay dividends? What is the dividend yield for Anthem?

Anthem declared a quarterly dividend on Wednesday, July 26th. Investors of record on Friday, September 8th will be given a dividend of $0.70 per share on Monday, September 25th. This represents a $2.80 dividend on an annualized basis and a dividend yield of 1.53%. The ex-dividend date of this dividend is Thursday, September 7th. This is a positive change from Anthem's previous quarterly dividend of $0.65. View Anthem's Dividend History.

How were Anthem's earnings last quarter?

Anthem, Inc. (NYSE:ANTM) posted its earnings results on Wednesday, July, 26th. The company reported $3.37 earnings per share for the quarter, topping the Zacks' consensus estimate of $3.23 by $0.14. The firm earned $22.20 billion during the quarter, compared to analyst estimates of $22.25 billion. Anthem had a return on equity of 13.13% and a net margin of 3.19%. Anthem's revenue for the quarter was up 4.3% compared to the same quarter last year. During the same period in the previous year, the firm earned $3.33 EPS. View Anthem's Earnings History.

Where is Anthem's stock going? Where will Anthem's stock price be in 2017?

19 analysts have issued 12 month target prices for Anthem's shares. Their forecasts range from $132.00 to $228.00. On average, they expect Anthem's stock price to reach $177.56 in the next year. View Analyst Ratings for Anthem.

What are analysts saying about Anthem stock?

Here are some recent quotes from research analysts about Anthem stock:

  • 1. Cantor Fitzgerald analysts commented, "This morning, Anthem reported 2Q17 results. Revenue was essentially in line with expectations while adjusted EPS of $3.37 compares to our estimate of $2.90 and FactSet consensus of $3.24." (7/26/2017)
  • 2. UBS AG analysts commented, "This afternoon, ANTM presented at a healthcare investor conference. The company reaffirmed its full-year 2017 EPS outlook of "at least" $11.50 but noted that the current consensus does not accurately reflect the quarterly seasonality. For example, last year, 1Q EPS included a $0.70 of EPS drag related to one extra day (leap year impact), which becomes a Y/Y tailwind this year in 1Q. Additionally, ANTM is adopting the new accounting standard associated with the stock options & stock-based compensation, which will add $0.10 to ANTM's EPS in 1Q17. Overall, ANTM expects its 1Q to represent 35-40% of its full-year EPS in 2017, compared with 31.5% in 2016. We are adjusting our model accordingly. We are raising our 1Q17 EPS estimate to $4.16 from $3.60, previously (our full-year 2017 EPS estimate remains unchanged at $11.60). Our 1Q17 EPS estimate now represents 36% of our full-year 2017 EPS est." (3/16/2017)
  • 3. Jefferies Group LLC analysts commented, "ANTM has managed better volume growth (3.4%) than its Commercial-risk heavy member mix would have suggested. That will slow in '17. P&L-wise, Medicare now is on much better footing, but Medicaid is a mixed bag - improvement in Iowa offset by Expansion rate headwinds. We missed the catchup trade on valuation, but aren't compelled to step in here." (2/2/2017)
  • 4. According to Zacks Investment Research, "Anthem’s earnings of $2.45 per share missed the Zacks Consensus Estimate by 1.6% and  declined 10.3% year over year owing to higher expenses. Anthem’s wide product portfolio, divestitures, prudent capital management, modest cash position, strategic acquisitions and ACO arrangements position it for long-term growth. Anthem has recently received high Medicare Star Quality Ratings from the Centers for Medicare & Medicaid Services (CMS). However, Anthem faces increasing regulatory hurdles from the U.S. Department of Justice (DOJ) over its proposed merger with Cigna and has been sued for the same. Though the company will challenge the case, the deal might fall apart and will lead to payment of $1.85 billion in severance charges to Cigna. Also, declining investment income, high debt levels and a weak public exchange business pose risks." (11/7/2016)

Who are some of Anthem's key competitors?

Who are Anthem's key executives?

Anthem's management team includes the folowing people:

  • Joseph R. Swedish, Chairman of the Board, President, Chief Executive Officer
  • John E. Gallina, Chief Financial Officer, Executive Vice President
  • Jose D. Tomas, Chief Human Resource Officer, Executive Vice President
  • Gloria M. McCarthy, Executive Vice President, Chief Administrative Officer
  • Thomas C. Zielinski, Executive Vice President, General Counsel
  • Brian T. Griffin, Executive Vice President, President - Commercial and Specialty Business
  • Peter D. Haytaian, Executive Vice President, President of Government Business Division
  • Craig E. Samitt M.D., Executive Vice President and Chief Clinical Officer
  • Ronald W. Penczek, Senior Vice President, Chief Accounting Officer, Controller
  • George A. Schaefer Jr., Lead Independent Director

Who owns Anthem stock?

Anthem's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Sanders Capital LLC (0.76%), APG Asset Management N.V. (0.59%), Russell Investments Group Ltd. (0.36%), Focused Investors LLC (0.29%), Tesco Pension Investment Ltd (0.28%) and Bank of Montreal Can (0.18%). Company insiders that own Anthem stock include Gloria M Mccarthy, Jose D Tomas, Joseph Swedish, Julie A Hill, Ramiro G Peru, Ronald W Penczek, Thomas C Zielinski, Wayne S Deveydt and William J Ryan. View Institutional Ownership Trends for Anthem.

Who sold Anthem stock? Who is selling Anthem stock?

Anthem's stock was sold by a variety of institutional investors in the last quarter, including APG Asset Management N.V., Russell Investments Group Ltd., Focused Investors LLC, Sanders Capital LLC, Swarthmore Group Inc., Factory Mutual Insurance Co., NGAM Advisors L.P. and Armstrong Shaw Associates Inc. CT. Company insiders that have sold Anthem stock in the last year include Gloria M Mccarthy, Jose D Tomas, Joseph Swedish, Julie A Hill, Ramiro G Peru, Ronald W Penczek, Thomas C Zielinski and William J Ryan. View Insider Buying and Selling for Anthem.

Who bought Anthem stock? Who is buying Anthem stock?

Anthem's stock was bought by a variety of institutional investors in the last quarter, including Tesco Pension Investment Ltd, Barometer Capital Management Inc., Harbour Capital Advisors LLC, First Quadrant L P CA, Bank of Montreal Can, James Investment Research Inc., Aperio Group LLC and Tavio Capital LLC. View Insider Buying and Selling for Anthem.

How do I buy Anthem stock?

Shares of Anthem can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Anthem's stock price today?

One share of Anthem stock can currently be purchased for approximately $183.52.

MarketBeat Community Rating for Anthem (NYSE ANTM)
Community Ranking:  2.3 out of 5 ( )
Outperform Votes:  407 (Vote Outperform)
Underperform Votes:  460 (Vote Underperform)
Total Votes:  867
MarketBeat's community ratings are surveys of what our community members think about Anthem and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Anthem (NYSE:ANTM) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 11 Hold Ratings, 8 Buy Ratings
Consensus Rating:Hold (Score: 2.42)
Consensus Price Target: $177.56 (3.25% downside)

Analysts' Ratings History for Anthem (NYSE:ANTM)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/26/2017Cantor FitzgeraldReiterated RatingBuy$210.00LowView Rating Details
7/14/2017Jefferies Group LLCReiterated RatingHold$204.00LowView Rating Details
7/14/2017Bank of America CorporationBoost Price TargetBuy$224.00 -> $228.00LowView Rating Details
7/13/2017Deutsche Bank AGBoost Price TargetHold$173.00 -> $185.00LowView Rating Details
7/12/2017Credit Suisse GroupInitiated CoverageNeutral -> Neutral$195.00LowView Rating Details
6/28/2017Citigroup Inc.Reiterated RatingBuy$205.00LowView Rating Details
6/6/2017Morgan StanleyInitiated CoverageEqual -> Equal Weight$196.00LowView Rating Details
4/28/2017Sanford C. BernsteinBoost Price TargetOutperform$202.00 -> $212.00LowView Rating Details
4/27/2017Royal Bank Of CanadaReiterated RatingOutperform -> Outperform$179.00 -> $183.00LowView Rating Details
2/2/2017Barclays PLCBoost Price TargetEqual Weight$159.00 -> $169.00N/AView Rating Details
1/4/2017Piper Jaffray CompaniesInitiated CoverageNeutral$151.00N/AView Rating Details
1/4/2017Stifel NicolausDowngradeBuy -> Hold$143.24 -> $155.00N/AView Rating Details
12/1/2016Wells Fargo & CompanyUpgradeMarket Perform -> OutperformN/AView Rating Details
11/22/2016Wolfe ResearchUpgradeMarket Perform -> Outperform$173.00N/AView Rating Details
11/3/2016Leerink SwannBoost Price TargetOutperform$155.00 -> $160.00N/AView Rating Details
10/17/2016J P Morgan Chase & CoDowngradeOverweight -> Neutral$154.00 -> $132.00N/AView Rating Details
9/22/2016Evercore ISIInitiated CoverageHold$133.00N/AView Rating Details
8/15/2016FBR & CoReiterated RatingMarket Perform$155.00N/AView Rating Details
7/27/2016WedbushReiterated RatingNeutral$150.00N/AView Rating Details
5/24/2016Sterne Agee CRTDowngradeBuy -> NeutralN/AView Rating Details
4/28/2016Oppenheimer Holdings, Inc.Reiterated RatingBuyN/AView Rating Details
4/8/2016Cleveland ResearchInitiated CoverageBuy$170.00N/AView Rating Details
4/5/2016Cowen and CompanyReiterated RatingOutperformN/AView Rating Details
4/1/2016Goldman Sachs Group, Inc. (The)Boost Price TargetBuy$160.00 -> $170.00N/AView Rating Details
10/29/2015BMO Capital MarketsLower Price TargetMarket Perform$175.00 -> $155.00N/AView Rating Details
(Data available from 7/27/2015 forward)


Earnings History for Anthem (NYSE:ANTM)
Earnings by Quarter for Anthem (NYSE:ANTM)
Earnings History by Quarter for Anthem (NYSE ANTM)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/26/2017Q2 2017$3.23$3.37$22.25 billion$22.20 billionViewN/AView Earnings Details
4/26/2017Q1 2017$3.85$4.68$21.23 billion$22.32 billionViewN/AView Earnings Details
2/1/2017Q416$1.61$1.76$20.96 billion$21.50 billionViewListenView Earnings Details
11/2/2016Q316$2.47$2.45$20.77 billion$21.13 billionViewListenView Earnings Details
7/27/2016Q216$3.23$3.33$20.53 billion$21.27 billionViewListenView Earnings Details
4/27/2016Q116$3.32$3.46$19.86 billion$20.30 billionViewListenView Earnings Details
1/27/2016Q415$1.20$1.14$19.89 billion$20.02 billionViewListenView Earnings Details
10/28/2015Q315$2.33$2.73$19.63 billion$19.77 billionViewListenView Earnings Details
7/29/2015Q215$2.75$3.10$19.64 billion$19.80 billionViewListenView Earnings Details
4/29/2015Q115$2.69$3.14$19.36 billion$18.85 billionViewListenView Earnings Details
1/28/2015Q414$1.72$1.73$18.99 billion$18.78 billionViewListenView Earnings Details
10/29/2014Q314$2.28$2.36$18.72 billion$18.40 billionViewListenView Earnings Details
7/30/2014Q214$2.28$2.44$18.25 billion$18.23 billionViewListenView Earnings Details
4/30/2014Q114$2.12$2.30$17.96 billion$17.65 billionViewListenView Earnings Details
1/29/2014Q413$0.87$0.87$17.75 billion$17.60 billionViewListenView Earnings Details
10/23/2013Q313$1.79$2.10$17.63 billion$17.70 billionViewListenView Earnings Details
7/24/2013Q2 2013$2.09$2.60$17.89 billion$17.60 billionViewListenView Earnings Details
4/24/2013Q1 2013$2.38$2.94$18.03 billion$17.55 billionViewListenView Earnings Details
1/23/2013Q4 2012$0.94$1.03$15.23 billion$15.54 billionViewListenView Earnings Details
11/7/2012Q312$1.84$2.09$15.31 billion$15.13 billionViewN/AView Earnings Details
7/25/2012$2.07$2.04ViewN/AView Earnings Details
4/25/2012$2.26$2.34ViewN/AView Earnings Details
1/25/2012$1.12$0.99ViewN/AView Earnings Details
10/26/2011$1.68$1.77ViewN/AView Earnings Details
7/27/2011$1.80$1.83ViewN/AView Earnings Details
4/27/2011$1.87$2.35ViewN/AView Earnings Details
1/26/2011$1.23$1.33ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Anthem (NYSE:ANTM)
Current Year EPS Consensus Estimate: $11.80 EPS
Next Year EPS Consensus Estimate: $13.00 EPS


Current Dividend Information for Anthem (NYSE:ANTM)
Next Dividend:9/25/2017
Annual Dividend:$2.60
Dividend Yield:1.42%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:25.22% (Trailing 12 Months of Earnings)
22.03% (Based on This Year's Estimates)
20.00% (Based on Next Year's Estimates)
Track Record:2 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for Anthem (NYSE:ANTM)

Dividend History by Quarter for Anthem (NYSE ANTM)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Anthem (NYSE:ANTM)
Insider Ownership Percentage: 0.36%
Institutional Ownership Percentage: 88.70%
Insider Trades by Quarter for Anthem (NYSE:ANTM)
Institutional Ownership by Quarter for Anthem (NYSE:ANTM)
Insider Trades by Quarter for Anthem (NYSE:ANTM)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/7/2017Ronald W PenczekSVPSell867$187.46$162,527.82View SEC Filing  
5/30/2017Ramiro G PeruDirectorSell2,681$181.58$486,815.98View SEC Filing  
5/24/2017Julie A HillDirectorSell555$180.56$100,210.80View SEC Filing  
4/3/2017Gloria M MccarthyEVPSell15,187$166.38$2,526,813.06View SEC Filing  
3/6/2017Ronald W PenczekSVPSell729$165.56$120,693.24View SEC Filing  
3/2/2017Ronald W PenczekSVPSell1,213$166.56$202,037.28View SEC Filing  
3/2/2017Thomas C ZielinskiEVPSell22,936$166.29$3,814,027.44View SEC Filing  
1/9/2017Jose D TomasEVPSell6,500$142.92$928,980.00View SEC Filing  
12/12/2016Joseph SwedishInsiderSell8,176$144.10$1,178,161.60View SEC Filing  
11/22/2016Ronald W PenczekSVPSell820$138.29$113,397.80View SEC Filing  
11/11/2016Joseph SwedishInsiderSell24,513$131.48$3,222,969.24View SEC Filing  
8/10/2016Thomas C ZielinskiEVPSell5,254$128.83$676,872.82View SEC Filing  
8/3/2016Ronald W PenczekSVPSell552$128.37$70,860.24View SEC Filing  
8/1/2016Gloria M MccarthyEVPSell4,186$130.39$545,812.54View SEC Filing  
7/28/2016William J RyanDirectorSell3,125$133.15$416,093.75View SEC Filing  
7/11/2016Joseph SwedishCEOSell8,171$131.49$1,074,404.79View SEC Filing  
7/1/2016Gloria M MccarthyEVPSell4,786$131.23$628,066.78View SEC Filing  
6/29/2016Ramiro G PeruDirectorSell3,125$130.00$406,250.00View SEC Filing  
6/1/2016Gloria M MccarthyEVPSell4,786$131.69$630,268.34View SEC Filing  
6/1/2016Joseph SwedishCEOSell11,628$132.02$1,535,128.56View SEC Filing  
5/2/2016Gloria M MccarthyEVPSell4,786$141.02$674,921.72View SEC Filing  
5/2/2016Joseph SwedishCEOSell11,626$141.19$1,641,474.94View SEC Filing  
4/14/2016Gloria M MccarthyEVPSell4,786$142.26$680,856.36View SEC Filing  
4/1/2016Joseph SwedishCEOSell11,626$139.38$1,620,431.88View SEC Filing  
3/11/2016Gloria M MccarthyEVPSell7,557$139.73$1,055,939.61View SEC Filing  
1/28/2016Joseph SwedishCEOSell11,626$129.47$1,505,218.22View SEC Filing  
12/28/2015Joseph SwedishCEOSell11,626$139.47$1,621,478.22View SEC Filing  
9/8/2015Wayne S. DeveydtCFOSell6,969$144.00$1,003,536.00View SEC Filing  
6/1/2015Ramiro G PeruDirectorSell4,709$167.91$790,688.19View SEC Filing  
5/28/2015William J RyanDirectorSell4,709$163.58$770,298.22View SEC Filing  
4/13/2015Gloria M MccarthyEVPSell43,933$155.02$6,810,493.66View SEC Filing  
3/3/2015John E GallinaCAOSell39,556$145.30$5,747,486.80View SEC Filing  
12/8/2014Wayne S DeveydtCFOSell4,404$127.72$562,478.88View SEC Filing  
10/13/2014Wayne S DeveydtCFOSell26,938$116.71$3,143,933.98View SEC Filing  
9/18/2014Kenneth R GouletEVPSell41,624$121.32$5,049,823.68View SEC Filing  
9/11/2014Samuel R Md NussbaumEVPSell20,000$120.00$2,400,000.00View SEC Filing  
9/9/2014Samuel R Md NussbaumEVPSell38,244$119.52$4,570,922.88View SEC Filing  
9/9/2014Wayne S DeveydtCFOSell4,404$120.00$528,480.00View SEC Filing  
9/8/2014Wayne S DeveydtCFOSell64,536$118.00$7,615,248.00View SEC Filing  
8/28/2014Samuel R Md NussbaumEVPSell40,000$116.05$4,642,000.00View SEC Filing  
8/27/2014Samuel R Md NussbaumEVPSell35,000$116.06$4,062,100.00View SEC Filing  
8/5/2014Wayne S DeveydtCFOSell30,000$110.95$3,328,500.00View SEC Filing  
1/31/2014George Schaefer, Jr.DirectorSell10,000$86.70$867,000.00View SEC Filing  
12/26/2013Richard ZoreticEVPSell20,000$91.79$1,835,800.00View SEC Filing  
12/13/2013John CannonEVPSell9,558$87.73$838,523.34View SEC Filing  
12/11/2013Gloria MccarthyEVPSell111,867$90.99$10,178,778.33View SEC Filing  
9/13/2013Samuel Md NussbaumEVPSell117,512$89.20$10,482,070.40View SEC Filing  
9/11/2013Samuel Md NussbaumEVPSell42,100$89.29$3,759,109.00View SEC Filing  
9/10/2013John CannonEVPSell13,799$87.33$1,205,066.67View SEC Filing  
9/5/2013Wayne S DeveydtCFOSell165,576$87.54$14,494,523.04View SEC Filing  
9/4/2013Randal L BrownEVPSell223,647$86.86$19,425,978.42View SEC Filing  
8/26/2013Warren JobeDirectorSell3,000$86.56$259,680.00View SEC Filing  
8/14/2013John CannonEVPSell114,336$86.95$9,941,515.20View SEC Filing  
8/6/2013Kenneth GouletEVPSell62,643$87.36$5,472,492.48View SEC Filing  
6/10/2013John CannonEVPSell97,759$78.27$7,651,596.93View SEC Filing  
6/5/2013William J RyanDirectorSell10,000$75.23$752,300.00View SEC Filing  
5/30/2013Lori A BeerEVPSell131,312$78.91$10,361,829.92View SEC Filing  
5/30/2013Warren Y JobeDirectorSell3,000$78.01$234,030.00View SEC Filing  
5/28/2013Lori A BeerEVPSell55,732$79.00$4,402,828.00View SEC Filing  
5/22/2013Gloria M MccarthyCAOSell33,919$78.71$2,669,764.49View SEC Filing  
2/25/2013George A Schaefer JrDirectorSell7,542$62.12$468,509.04View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Anthem (NYSE:ANTM)
Latest Headlines for Anthem (NYSE:ANTM)
DateHeadline logoEdited Transcript of ANTM earnings conference call or presentation 26-Jul-17 12:30pm GMT - July 27 at 3:36 PM logoAnthem, Inc. :ANTM-US: Earnings Analysis: Q2, 2017 By the Numbers : July 27, 2017 - July 27 at 3:36 PM logoAnthem Inc (ANTM) Considers Exiting More Obamacare Markets in 2018 - - July 26 at 9:29 PM logo[$$] Anthem Seeks Clarity from Health Law Debate - July 26 at 9:29 PM logoAnthem's (ANTM) Buy Rating Reaffirmed at Cantor Fitzgerald - July 26 at 4:31 PM logoAnthem beats 2Q profit forecasts - July 26 at 4:26 PM logoAnthem, Inc. (NYSE:ANTM) Increases Dividend to $0.70 Per Share - July 26 at 12:04 PM logoAnthem, Inc. (NYSE:ANTM) Issues Quarterly Earnings Results - July 26 at 11:25 AM logoExpress Scripts says any new Anthem contract would be unfavorable - Reuters - July 26 at 1:50 AM logoExpress Scripts bearish on new Anthem contract - Nasdaq - July 25 at 8:48 PM logoExpress Scripts bearish on new Anthem contract - July 25 at 8:48 PM logoAnthem: Tread Carefully Into Earnings - July 24 at 1:13 PM logoWhat to Expect from Anthem (ANTM) this Earnings Season? - July 24 at 1:12 PM logoAnthem, Inc. (ANTM) Downgraded by BidaskClub - July 23 at 8:08 PM logoAnthem could consider build-to-suit option for 1800-job Atlanta IT services hub (SLIDESHOW) - Atlanta Business Chronicle - July 20 at 10:16 PM logoAnthem, Inc. (ANTM) to Release Earnings on Wednesday - July 19 at 9:00 AM logoNasdaq and S&P 500 Jump to New Records, Dow Tanks - - July 18 at 10:23 PM logoAs Obamacare repeal falters, insurers start to press on subsidies - Reuters - July 18 at 10:23 PM logoUnitedHealth beats profit estimates after Obamacare exit - Reuters - July 18 at 5:22 PM logoEmployers Challenged by Expensive and Time-Consuming Specialty Drugs, According to Benefits Quarterly Magazine - July 17 at 4:15 PM logoAnthem, Inc. (NYSE:ANTM) Given "Hold" Rating at Jefferies Group LLC - July 15 at 3:34 PM logo[$$] States to Health Insurers: Please Come Back - July 14 at 10:43 PM logoSidelined healthcare lobby stymies Republican healthcare effort - Reuters - July 14 at 5:43 PM logoWhy Anthem (ANTM) is Such a Great Value Stock Pick Right Now - July 14 at 5:43 PM logoAnthem, Inc. (ANTM) Price Target Raised to $228.00 - July 14 at 5:34 PM logo$22.29 Billion in Sales Expected for Anthem, Inc. (NYSE:ANTM) This Quarter - July 14 at 3:54 PM logo[$$] Anthem Files Civil Suit Against Insys Therapeutics - July 13 at 7:13 PM logoAnthem files lawsuit against Insys Therapeutics - July 13 at 7:13 PM logoAnthem, Inc. (NYSE:ANTM) Price Target Increased to $185.00 by Analysts at Deutsche Bank AG - July 13 at 6:42 PM logoSessions to Unveil Health-Care Fraud Crackdown This Week, Sources Say - July 12 at 4:24 PM logoCigna Buys Zurich Insurance To Expand In UAE, Shares Gain - July 12 at 3:43 PM logo Brokerages Anticipate Anthem, Inc. (ANTM) Will Post Earnings of $3.26 Per Share - July 12 at 8:32 AM logoNew Strong Buy Stocks for July 11th - Nasdaq - July 11 at 5:06 PM logoAnthem, Inc. (ANTM) Given Consensus Rating of "Hold" by Analysts - July 10 at 8:46 AM logoAnthem to Hold Conference Call and Webcast to Discuss Second Quarter Results on July 26, 2017 - July 6 at 5:15 PM logoHow To YieldBoost Anthem To 3.7% Using Options - July 5 at 4:28 PM logo[$$] What Anthem's Settlement Reveals About Future Data Breach Suits - July 3 at 3:46 PM logo[$$] Centene to Offer ACA Exchange Plans in 40 Missouri Counties in 2018 - June 30 at 3:59 PM logoFailed Walgreens-Rite Aid Deal Telegraphs Potential Antitrust Policy Under Trump - June 29 at 4:57 PM logoAnthem's Exit Creates Obamacare `Crisis' for Rural Nevadans - June 28 at 9:12 PM logo[$$] Anthem Pulling Back on Offering ACA Plans in Nevada - June 28 at 9:12 PM logoOhio, Missouri have biggest bare spots for 2018 ACA individual health coverage - June 28 at 4:04 PM logoAvalon Healthcare Solutions Names Chief Growth Officer and Chief Operating Officer - June 28 at 4:04 PM logoExpress Scripts Gains from Increased Generic Utilization - June 28 at 4:04 PM logo7 Dividend Stocks That Guarantee Growth and Stability - June 28 at 4:04 PM logoAnthem, Inc. (ANTM) Receives "Buy" Rating from Citigroup Inc. - June 28 at 1:50 PM logoWhich Industry Spends the Most on Lobbying? - June 27 at 3:40 PM logoThe Latest: 3 GOP senators threaten to oppose health bill - June 27 at 2:45 AM logoNoteworthy ETF Outflows: JKD, MO, BIIB, ANTM - Nasdaq - June 26 at 9:04 PM logoThe Latest: Audit says Senate bill would leave 22m uninsured - June 26 at 4:46 PM



Anthem (ANTM) Chart for Thursday, July, 27, 2017

This page was last updated on 7/27/2017 by Staff